Kura Oncology (KURA) Reports In-Line Q3 EPS

Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.63), in-line with the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• HighPeak Energy mulls sale - Reuters
• Active options: TSLA NVDA INTC AAPL SPCX AMD MU AMZN CRWV
• Haemonetics (HAE) spreader of 500 contracts of November 115 and 130 calls as share price up 2.5%